Assessment of the pharmaceutical active compounds removal in wastewater treatment systems at enantiomeric level. Ibuprofen and naproxen

Chemosphere

Volumn 75, Issue 2, 2009, Pages 200-205

  Matamoros, Víctor ^a   Hijosa, María ^a,b   Bayona, Josep M ^a  

^a INSTITUTE OF ENVIRONMENTAL ASSESSMENT AND WATER RESEARCH   (Spain)

^b UNIVERSITY OF LEÓN   (Spain)

Author keywords

Chiral pharmaceuticals; Enantiomeric fraction; Enantiomers; Removal efficiency; Wastewater treatment

Indexed keywords

ACTIVATED SLUDGES; AEROBIC AND ANAEROBIC CONDITIONS; AEROBIC CONDITIONS; ANAEROBIC CONDITIONS; ASYMMETRIC CARBONS; CHIRAL PHARMACEUTICALS; CONSTRUCTED WETLANDS; ENANTIOMERIC FRACTION; ENANTIOSELECTIVE; ENANTIOSELECTIVE DEGRADATIONS; FLOW CONFIGURATIONS; NAPROXEN; PHARMACEUTICAL ACTIVE COMPOUNDS; PILOT-SCALE; RAW SEWAGES; REMOVAL EFFICIENCY; SAND FILTERS; TREATMENT SYSTEMS; WASTE WATER TREATMENT PLANTS; WASTEWATER EFFLUENTS; WASTEWATER TREATMENT SYSTEMS;

BIOCHEMICAL OXYGEN DEMAND; CHIRALITY; DEGRADATION; DRUG PRODUCTS; EFFLUENTS; ENANTIOMERS; GAMMA RADIOGRAPHY; REMOVAL; SEWAGE; WASTEWATER; WASTEWATER RECLAMATION; WATER RECYCLING; WATER TREATMENT PLANTS; WETLANDS;

WASTEWATER TREATMENT;

ACTIVATED SLUDGE; ASSESSMENT METHOD; CONSTRUCTED WETLAND; DEGRADATION; DRUG; EFFLUENT; POLLUTANT REMOVAL; WASTEWATER; WATER TREATMENT;

IBUPROFEN; NAPROXEN; STEREOISOMERISM; WASTE DISPOSAL, FLUID; WATER PURIFICATION;

EID: 61849146899     PISSN: 00456535     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chemosphere.2008.12.008     Document Type: Article

References (25)

1. Adams S.S. Pharmacological differences between the optical isomers of ibuprofen: evidence for metabolic inversion of the (-) isomer. J. Pharm. Pharmacol. 28 (1976) 256-257
2. Ali I., and Abaul-Enein H.Y. Chiral Pollutants: Distribution (2004), Toxicity and Analysis by Chromatography and Capillary Electrophoresis, John Wiley and Sons, Chichester
3. Boneberg E.M., Zou M.H., and Ullrich V. Inhibition of cyclooxygenase-1 and -2 by R(-)- and S(+)-ibuprofen. J. Clin. Pharmacol. 36 (1996) 16S-19S
4. Buser H.-R., Poiger T., and Müller M.D. Occurrence and environmental behaviour of chiral pharmaceutical drug ibuprofen in surface waters and in wastewater. Environ. Sci. Technol. 33 (1999) 2529-2535
5. Caselles-Osorio A., and García J. Performance of experimental horizontal subsurface flow constructed wetlands fed with dissolved or particulate organic matter. Water Res. 40 (2006) 3603-3611
6. Cooper P.F., Job G.D., Green M.B., and Shutes R.B.E. Reed Beds and Constructed Wetlands for Wastewater Treatment (1996), WRc Swindon, UK
7. Daugthon C.G., and Ternes T.A. Pharmaceuticals and personal care products in the environment: Agent of subtable change?. Environ. Health Persp. 107 (1999) 907-938
8. Fono L.J., and Sedlak D.L. Use of the chiral pharmaceutical propranolol to identify sewage discharges into surface waters. Environ. Sci. Technol. 39 (2005) 9244-9252
9. Garcia J., Aguirre P., Barragan J., Mujeriego R., Matamoros V., and Bayona J.M. Effect of key design parameters on the efficiency of horizontal subsurface flow constructed wetlands. Ecol. Eng. 25 (2005) 405-418
10. Harrison I., Williams G.M., and Carlick C.A. Enantio selective biodegradation of mecoprop in aerobic and anaerobic microcosms. Chemosphere 53 5 (2003) 539-549
11. Heberer T. Tracking persistent pharmaceutical residues from municipal sewage to drinking water. J. Hydrol. 266 (2002) 175-189
12. Kaiser D.G., Vangiessen G.J., Reischer R.J., and Wechter W.J. Isomeric inversion of ibuprofen (R)-enantiomer in humans. J. Pharm. Sci. 65 (1976) 269-273
13. Knoche B., and Blaschke G. Investigations on the in vitro racemization of thalidomide by high-performance liquid chromatography. J. Chromatogr. A 666 (1994) 235-240
14. Kolpin D.W., Furlong E.T., Meyer M.T., Thurman E.M., Zaugg S.D., Barber L.B., and Buxton H.T. Pharmaceuticals, hormones, and other organic wastewater contaminants in US streams, 1999-2000: A national reconnaissance. Environ. Sci. Technol. 36 (2002) 1202-1211
15. Matamoros V., Arias C.A., Brix H., and Bayona J.M. Removal of pharmaceuticals and personal care products (PPCPs) from urban wastewater in a pilot vertical subsurface-flow constructed wetland and a sand filter. Environ. Sci. Technol. 41 (2007) 8171-8177
16. Matamoros V., and Bayona J.M. Elimination of pharmaceuticals and personal care products in subsurface flow constructed wetlands. Environ. Sci. Technol. 40 (2006) 5811-5816
17. Matamoros V., Caselles-Osorio A., García J., and Bayona J.M. Behaviour of pharmaceutical products and biodegradation intermediates in horizontal subsurface flow constructed wetland. A microcosm experiment. Sci. Total Environ. 394 (2008) 171-176
18. Matamoros V., García J., and Bayona J.M. Behavior of selected pharmaceuticals in subsurface flow constructed wetlands: a pilot-scale study. Environ. Sci. Technol. 39 (2005) 5449-5454
19. Muller N., Payan E., Lapicque F., Bannwarth B., and Netter P. Pharmacological aspects of chiral nonsteroidal antiinflammatory drugs. Fund. Clin. Pharmacol. 4 (1990) 617-634
20. Ternes T.A. Occurrence of drugs in German sewage treatment plants and rivers. Water Res. 32 (1998) 3245-3260
21. Thomason M.J., Rhys-Williams W., Hutt A.J., Lloyd A.W., and Hanlon G.W. Demonstration of the chiral inversion of ibuprofen by Verticillium lecanii in non-growing cultures. Lett. Appl. Microbiol. 23 (1996) 417-420
22. Vymazal J. Horizontal sub-surface flow and hybrid constructed wetlands systems for wastewater treatment. Ecol. Eng. 25 (2005) 478-490
23. Williams G.M., Harrison I., Carlick C.A., and Crowley O. Changes in enantiomeric fraction as evidence of natural attenuation of mecoprop in a limestone aquifer. J. Cont. Hydrol. 64 (2003) 253-267
24. Winkler M., Lawrence J.R., and Neu T.R. Selective degradation of ibuprofen and clofibric acid in two model river biofilm systems. Water Res. 35 (2001) 3197-3205
25. Wong C. Environmental fate processes and biochemical transformations of chiral emerging organic pollutants. Anal. Bioanal. Chem. 386 (2006) 544-558